Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiongge Shujin Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Hospital of Integrated Traditional Chinese and Western Medicine at Southern Medical University. It is primarily indicated for the treatment of chronic insomnia and migraine without aura. The formula is composed of several herbal ingredients, notably *Ligusticum chuanxiong* and *Pueraria lobata* (from which the name "Xiongge" is derived). Pharmacologically, it is thought to work by improving cerebral blood circulation, modulating neurotransmitters such as serotonin (5-HT), and reducing levels of calcitonin gene-related peptide (CGRP), which is a key mediator in migraine pathogenesis. In TCM theory, it functions to activate blood circulation, resolve stasis, and unblock the meridians to relieve pain and calm the mind.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiongge Shujin Decoction.